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During the past 20 years, cutaneous leishmaniasis has 
emerged as a major public health threat in Morocco. We 
describe distribution of Leishmania major and L. tropica in 
Morocco and a new focus of cutaneous leishmaniasis due 
to L. infantum. We recommend using molecular techniques 
to diagnose suspected leishmaniasis cases.
L
eishmaniasis, a vectorborne parasitic disease, affects 
1.5–2 million people annually. In >100 countries 
whose populations are at risk for the disease, the disease in-
ﬂ  icts a high economic cost (1,2). Additionally, large-scale 
emergence and reemergence have been recently reported in 
many Mediterranean countries, including Morocco (1,3).
Cutaneous leishmaniasis (CL) caused by Leishmania 
major has been reported in Morocco since 1914 (4); until 
recently, however, it was largely conﬁ  ned to arid Saharan 
regions (4,5). In 2001, the Moroccan Ministry of Health 
(MMH) reported 2,028 CL cases caused by L. major and L. 
tropica (6). Of the 3 clinically important Leishmania spe-
cies (L. major, L. tropica, L. infantum), L. tropica has the 
largest geographic distribution and is considered a public 
health threat by the MMH. L. tropica CL has been reported 
in Azilal, Essaouira, Taza, Fes, the province of Chichaoua, 
and central Morocco (5,7–10).
Accurate diagnosis and treatment of CL requires posi-
tive identiﬁ  cation of the causative species of parasite (11). 
Often, however, traditional diagnostic methods such as 
analysis of clinical symptoms, microscopic identiﬁ  cation, 
and parasite culture are performed in place of molecular 
diagnostic techniques, such as PCR. Problematically, all 
Leishmania species have similar morphology, and several 
species capable of causing both CL and visceral leishmani-
asis (VL) may exist in the same locales.
We update the current epidemiologic proﬁ  le of Leish-
mania spp. in Morocco by using archived clinical samples 
tested by PCR. We provide economic and epidemiologic 
rationales for our recommendation that species-speciﬁ  c 
identiﬁ   cation be performed for all cases of suspected 
leishmaniasis.
The Study
Tissue samples were taken from 27 patients with sus-
pected CL who had consulted the health centers from March 
2005 to March 2006. Local reference laboratories evaluated 
all stained slides by light microscopy and positively identi-
ﬁ  ed Leishmania amastigotes. Patients had no history of travel 
and were assumed to been infected in Morocco; all received 
free intralesional injections of meglumine antimoniate (Glu-
cantime; Sanoﬁ  -Aventis, Bridgewater, NJ, USA) until total 
recovery, according to the protocol in the MMH leishmani-
asis control manual. Samples were collected in areas of Mo-
rocco known for high CL incidence: north (Sidi Kacem), 
center (Beni Mellal and Boulemane), southeast (Errachidia), 
and southwest (Taroudant and Ouarzazate) (Figure 1).
DNA extraction and PCR analysis by ampliﬁ  cation of 
the ribosomal internal transcribed spacer 1 (ITS1), using 
stained slides, was performed as described by Schonian et 
al. (12). We used 0.6-nM primers and PCR-Ready Supreme 
mix (Syntezza Bioscience, Jerusalem, Israel) in 25 μL of 
total reaction. Leishmania DNA (10 ng/reaction) from ref-
erence strains L. tropica (MHOM/AZ/1974/SAF-K27), 
L. major (MHOM/TM/1973/5ASKH), and L. infantum 
(MHOM/TN/1980/IPT1) were used as positive controls. 
Negative controls for extracted DNA and PCR analysis 
were included. After ampliﬁ  cation, the PCR product was 
digested with 1.5 μL BsuRI endonuclease (MBI Fermen-
tas, Burlington, Ontario, Canada), and all digested products 
were analyzed by agarose gel electrophoresis (12).
All patients had classic symptoms of CL, from small 
erythematous papules to nodules and ulcerative lesions. Pa-
tients’ ages varied from 1.25 to 70 years. The sample com-
prised 44% male and 56% female patients (Table). Papu-
lar lesions, nodular lesions, or both were present in 30% 
of the CL patients; ulcerative lesions, in 52%. Neither the 
papular/nodular nor the ulcerative forms correlated with a 
particular Leishmania species. The erythematous clinical 
form was present in 18% of total case-patients and in 63% 
of case-patients from the Sidi Kacem region.
Undigested ITS1 amplicons from the 27 slides pro-
duced a band of 300–350 bp (data not shown), which con-
ﬁ  rmed the presence of Leishmania DNA. Band patterns 
from the digested samples were compared with digested 
standards for each reference strain and identiﬁ  ed the para-
site species (Figure 2) as follows: L. major, 3 samples each 
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from Ouarzazate and Errachidia; L. tropica, 2 samples from 
Taroudant, 4 from Beni Mellal, and 7 from Boulemane; L. 
infantum, 8 samples from Sidi Kacem.
Conclusions
CL caused by L. major or L. tropica and VL caused by 
L. infantum have been reported in Morocco (5–9). PCR on 
archived tissue samples enabled us to investigate the epi-
demiology of CL in disease-endemic regions of Morocco 
and identify those species responsible for this disease in 
several new foci (Table). Our results, together with those of 
previous studies (5–9; unpub. data from MMH, 2001), in-
dicate that CL caused by L. tropica is found throughout the 
center of the country in a band stretching from the Atlantic 
Ocean along the length of the Atlas Mountains almost to 
the Mediterranean Sea. CL caused by L. major is present 
in the desert region south of the Atlas Mountains in a strip 
bordering the Sahara Desert (Figure 1).
We report on a focus of CL in Morocco caused by L. 
infantum, 8 samples from Sidi Kacem. In Morocco, the 
only previous human CL case caused by L. infantum was 
reported in 1996, within an active focus of VL (13). The 
northern coastal regions of Morocco are endemic for hu-
man and canine VL. As in other VL-endemic regions sur-
rounding the Mediterranean Sea, this disease is caused by 
L. infantum (3). Although it is unusual for this parasite to 
cause CL, our ﬁ  nding is similar to a recent report from Tu-
nisia, where L. infantum was shown to cause sporadic CL 
in regions endemic for VL. It appeared to have emerged in 
a new region of the country and was suggested to be more 
prevalent than originally indicated (14).
CL and VL overlap in many provinces of central Mo-
rocco; anthroponotic foci of L. tropica CL are found in Fes 
and Taza (7–9) (Figure 1), not far from existing VL foci 
including Sidi Kacem. Furthermore, several cases of ca-
nine VL caused by L. tropica have been reported in regions 
where canine VL is caused by L. infantum.
The nodular form of CL was caused by all 3 species; 
ulcerative lesions were seen only with CL caused by L. 
tropica and L. major. Of the 8 patients in Sidi Kacem with 
L. infantum infection, 5 showed the atypical erythematous 
papular form. These ﬁ  ndings agree with results of studies 
in northern Morocco (7). The overlapping distribution of 
parasite species, causing diseases with similar clinical pic-
tures, demonstrates the need for additional epidemiologic 
and ecologic studies of CL in conjunction with species 
identiﬁ  cation. This is especially important as traditional 
methods of determining infection from patient history and 
microscopic examination prove increasingly unreliable. 
PCR can be performed rapidly on fresh or archived samples 
and does not require culturing of large amounts of para-
sites. In addition, PCR costs have come down considerably, 
and costs can be further reduced by sending samples by 
regular mail to a central facility.
Recent studies document the emergence of new Leish-
mania foci and the coexistence of multiple Leishmania 
species in the same geographic locale, including much of 
northern Africa (14). We recommend that treatment proto-
cols, particularly in areas of coexistence, be predicated on 
diagnosis of not only the clinical form—CL versus VL—
but additionally the disease-causing species.
In Morocco, local physicians and healthcare adminis-
trators often do not realize that different species of Leish-
Figure 1. Molecular epidemiology of cutaneous leishmaniasis (CL) 
in Morocco. L., Leishmania.
Table. Distribution of cutaneous leishmaniasis, 27 patients, Morocco, 2005–2006 
Geographic origin  No. cases  Age range, y  Sex Clinical lesions  Leishmania species 
Taroudant  2 5–20 1M, 1F  Nodular (2) L. tropica
Beni Mellal  4 3–11 3M, 1F  Ulcerative (4) L. tropica
Boulemane 7 1.25–60 4M, 3F  Ulcerative (5)
Papulonodular (2)
L. tropica
Ouarzazate 3 0.25–52 1M, 2F  Ulcerative (2)
Nodular (1)
L. major
Errachidia 3 3–39 1M, 2F  Ulcerative (3) L. major
Sidi Kacem  8 2–70 2M, 6F  Erythematous (5)
Papulonodular (2)
Nodular (1)
L. infantumDISPATCHES
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mania require differential treatments, which can result in a 
failure to diagnose more serious disease. Risk for metastat-
ic lesions with L. major is almost zero. However, recurrent 
failure of local treatments (paromomycin and intralesional 
sodium stibogluconate) against L. tropica was evident (11). 
Because L. tropica, and now L. infantum, cause both VL 
and CL, a physician treating a cutaneous lesion may over-
look visceral disease, and a host of costlier health problems 
may ensue. A simple, sensitive PCR test could easily re-
duce such risk. Further surveillance of cases and suspected 
cases from these foci should conﬁ  rm the results of this lim-
ited study.
Recent implementation of PCR-based diagnosis in 
an outbreak in northern Algeria increased the positive 
diagnosis of CL by 69% over cases diagnosed by using 
microscopy alone (15). Furthermore, anthroponotic CL 
caused by L. tropica is limited to parts of southern Eu-
rope, Asia, and Africa; diagnosis and treatment of the 
disease at its earliest stage is of paramount importance 
for reduction of the human reservoir. Failure to promptly 
diagnose and treat all cases will result in continued dis-
semination of the parasite.
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Figure 2. Comparison between endonuclease BsuRI digestion 
patterns of internal transcribed spacer 1–PCR products from clinical 
samples and reference Leishmania strains. Clinical samples, lanes 
1–6: lane 1, Boulmane; lane 2, Ouarzazate; lanes 3–6, Sidi Kacem. 
Reference strains, lanes 7–9: lane 7, L. tropica (MHOM/SU/1974/
SAF-K27); lane 8, L. major (MHOM/TM/1973/5ASKH); lane 9, L. 
infantum (MHOM/TN/1980/IPT1). MW, DNA molecular weight 
marker in base pairs (bp). 